Literature DB >> 2503862

Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

M Papotti1, L Macrì, G Finzi, C Capella, V Eusebi, G Bussolati.   

Abstract

A group of human breast carcinomas shows morphologic and histochemical evidence of neuroendocrine (NE) differentiation. This study presents a structural, immunologic, and electron microscopic analysis of 51 cases in order to establish positive criteria for identification of these tumors, their incidence, variants, and biological behavior. Argyrophilia (by the Grimelius procedure), presence of chromogranin A and/or B, and of synaptophysin are the most reliable histochemical features, correlating with the ultrastructural demonstration of dense-core secretory granules and of clear vesicles of the synaptic type. Structural features alone may be suggestive, but do not prove NE differentiation, which has to be established by additional techniques. Seven histologic types were identified, but those herein described as types A, B, and C, which show cohesive, mucoid, and mixed patterns, respectively, comprise the vast majority of the tumors. Rare NE carcinomas of the breast show structural similarities to Merkel cell and oat cell carcinomas, and behave as highly aggressive tumors. Type B (mucinous) tumors proved to be relatively indolent, while the most frequent types of endocrine tumors (types A and C) have an intermediate grade of malignancy. The analysis of a consecutive series of 100 cases of breast cancer indicates that about 8% of breast carcinomas display some degree of NE differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503862

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  35 in total

1.  Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ.

Authors:  J D Coyne; P A Dervan; L Barr; A D Baildam
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Solid papillary carcinoma of the breast: imprint cytological and histological findings.

Authors:  Naoto Kuroda; Nokiaki Fujishima; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

Review 3.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

4.  Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases.

Authors:  Gen-You Yao; Ji-Lin Zhou; Mao-De Lai; Xiao-Qing Chen; Pei-Hui Chen
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  A Rare Entity of Breast Cancer: Primary Neuroendocrin Carcinoma.

Authors:  Mehmet Abdussamet Bozkurt; Ali Kocataş; Yasemin Özkan; Mustafa Uygar Kalaycı; Halil Alış
Journal:  J Breast Health       Date:  2014-10-01

6.  A Rare Breast Tumor Confused with Ductal Carcinoma in Situ, Primary Solid Neuroendocrine Carcinoma.

Authors:  Ömer Alıcı; Serap Korkmaz Aydoğdu
Journal:  J Breast Health       Date:  2014-04-01

7.  Neuroendocrine carcinoma of breast: a rare case vignette.

Authors:  Nandeesh M; Anitha T K; Shravan Rajpurohit; Santosh R
Journal:  J Clin Diagn Res       Date:  2013-11-10

8.  Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma.

Authors:  Noriko Kimura; Ryuichi Yoshida; Shin-ichiro Shiraishi; Monika Pilichowska; Noriaki Ohuchi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

9.  A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy.

Authors:  Xiaolong Wei; Chunfa Chen; Didi Xi; Jinwen Bai; Wenhe Huang; Luoxiang Rong; Mingyao Wu; Guojun Zhang
Journal:  Front Med       Date:  2014-08-06       Impact factor: 4.592

Review 10.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.